Hydroquinidine
- Generic Name
- Hydroquinidine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H26N2O2
- CAS Number
- 1435-55-8
- Unique Ingredient Identifier
- 8P68XPY4HG
- Background
Hydroquinidine is under investigation in clinical trial NCT00927732 (Hydroquinidine Versus Placebo in Patients With Brugada Syndrome).
- Associated Conditions
- Atrial Fibrillation or Flutter, Paroxysmal Supraventricular Tachycardia (PSVT), Sinus Rhythm, Supraventricular Arrhythmias, Ventricular Ectopic Beat, Ventricular Tachycardia (VT)
- Associated Therapies
- -
Hydroquinidine Versus Placebo in Patients With Brugada Syndrome
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2014-11-24
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 64
- Registration Number
- NCT00927732
- Locations
- 🇫🇷
CHU Amiens, Amiens, France
🇫🇷CHRU Lille, Lille, France
🇫🇷CHU Nantes, Nantes, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath